Saving Sight: A Simple Approach for Screening of Diabetic Retinopathy in Primary Care

Released On
December 27, 2021

Expires On
December 26, 2022

Media Type

Completion Time
30 minutes

Primary Care Clinicians, Diabetes

Diabetic retinopathy; diabetic macular edema; screening, endocrinology, diabetes, ophthalmology

Scroll to the Bottom of this Information to Begin this Course

This educational activity is jointly provided by Postgraduate Institute for Medicine and DKBmed, LLC.

This activity is supported by an independent educational grant from Regeneron Pharmaceuticals, Inc.

Credit Available

  • Physicians — maximum of 0.5 AMA PRA Category 1 Credit(s)
  • Nurses — 0.5 Contact Hours

All other health care professionals completing this course will be issued a statement of participation.

Target Audience

This activity is intended for primary care clinicians and allied health providers who treat patients with type 2 diabetes.

Program Overview

These activities explain the pathophysiology of diabetic retinopathy/diabetic macular edema, the importance of early screening, and the therapeutic treatment options including VEGF inhibitor.

Learning Objectives

Upon completion of this activity, participants should be better able to:

  • Explain the pathophysiology of diabetic retinopathy/diabetic macular edema, the importance of early screening, and the therapeutic treatment options including VEGF inhibitors.
  • Use retinal screening devices, if available, or refer patients with diabetes to an eye care professional for regular screening in accordance with ADA or AAO guidelines.


Aravinda Rao, MD

Clinical Associate Professor of Ophthalmology
Vitreoretinal Fellowship Director
LSU Ophthalmology
LSU Eye Clinic
Our Lady of the Lake Regional Medical Center
Baton Rouge, LA

Cory J. Boudreaux, OD

Focal Point Eye Care
Baton Rouge, LA

Joint Accreditation Statement

In support of improving patient care, this activity has been planned and implemented by the Postgraduate Institute for Medicine and DKBmed, LLC. Postgraduate Institute for Medicine is jointly accredited by the American Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.

Physician Credit Designation

The Postgraduate Institute for Medicine designates this enduring activity for a maximum of 0.5 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

AAPA Credit Designation Statement – Enduring Materials

Postgraduate Institute for Medicine has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 0.5 AAPA Category 1 CME credits. Approval is valid until December 26, 2022. PAs should only claim credit commensurate with the extent of their participation.

Nursing Continuing Education

The maximum number of hours awarded for this Continuing Nursing Education activity is 0.5 contact hours.

Media: Internet

Disclosures of Conflicts of Interest

Postgraduate Institute for Medicine (PIM) requires faculty, planners, and others in control of educational content to disclose all their financial relationships with ineligible companies. All identified conflicts of interest (COI) are thoroughly vetted and mitigated according to PIM policy. PIM is committed to providing its learners with high quality accredited continuing education activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of an ineligible company.

Faculty / Presenter Reported Financial Relationship

Aravinda Rao, MD has nothing to disclose.

Corey Boudreaux, DO has nothing to disclose.

Planners and Managers

The PIM planners and managers have nothing to disclose. The DKBmed planners and managers have nothing to disclose.

Request for Credit

There are no fees for participating and receiving CME/CE credit for this activity.

If you wish to receive acknowledgment for completing this activity, please complete the evaluation.

Launch: December 27, 2021
Expiration: December 26, 2022

Course Viewing Requirements

Supported Browsers:
Internet Explorer 8.0+ for Windows 2003, Vista, XP, Windows 7, Windows 8.1 and above
Google Chrome 28.0+ for Windows, Mac OS, or Linux
Mozilla Firefox 23.0+ for Windows, Mac OS, or Linux
Safari 6.0+ for Mac OSX 10.7 and above

Supported Phones & Tablets:
Android 4.0.3 and above
iPhone/iPad with iOS 6.1 or above

Disclosure of Unlabeled Use

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications.

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.


Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.

Contact Information

If you have questions regarding the certification of this activity, please contact PIM via email at

For technical issues, please. contact